StrokeNCT07202806
A Study on the Application of Aromatherapy Combined With Transcranial Magnetic Stimulation in Insomnia of Stroke Patients
A study testing Aromatherapy in people with Stroke, run by Dandan Wu.
Trial summary
Exploring the application efficacy of aromatherapy combined with transcranial magnetic stimulation on insomnia in patients with cerebral stroke Read more about this study
- Who is it for?
- Ages 24 to 65 years
- Conditions the study is for
- Stroke
- What is being tested?
- Aromatherapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 6 participants
- Where
- No sites listed yet
- Study dates
- 8 Oct 2025to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 24 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Clinical diagnosis of stroke
- Insomnia patients
- Sign the informed consent form, cooperate voluntarily
- Accord with the diagnosis of "insomnia" in traditional Chinese medicine
- Evaluation has no taboo on transcranial magnetism
- The age range is between 24 and 65
Who cannot join
- Disturbance of consciousness
- Cognitive impairment
- Mental abnormality
- Sleep apnea syndrome
- Restless leg syndrome
About this study
Exploring the application efficacy of aromatherapy combined with transcranial magnetic stimulation on insomnia in patients with cerebral stroke
- Conditions
- Stroke
- Being tested
- Aromatherapy
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AromatherapyBehavioural
1.Aromatherapy is made from self-made sachet of traditional Chinese medicine.Its components (albizzia, Angelica dahurica, cardamom, Polygala, Evodia, Magnolia, Acorus calamus) are 10g each. Place the pillow 1 hour in advance. It is forbidden to play with your mobile phone or turn off the lights before going to bed.
| Study group | Role | What they receive |
|---|---|---|
| transcranial magnetic stimulation | No intervention | Not described |
| Aromatherapy + transcranial magnetic stimulation | Experimental | Experimental:Aromatherapy + transcranial magnetic stimulation
1.Aromatherapy is made from self-made sachet of traditional Chinese medicine.Its components (albizzia, Angelica dahurica, cardamom, Polygala, Evodia, Magnolia, Acorus calamus) are 10g each. Place the pillow 1 hour in advance. It is forbidden to play with your mobile phone or turn off the lights before going to bed.2.The r repetitive transcranial magnetic acupuncture apparatus produced by Jiangxi brain Control Technology Development Co., Ltd. is used and operated by professional therapists.Before treatment, the resting exercise threshold of each patient was tested: 10 pulse stimuli were given to find out the lowest stimulus intensity that could cause more than 50 microvolts.Parameter setting: 90% RMT 1Hz, each sequence lasts 12s, stimulation 10s, interval 2s. The treatment time was 20min/, once per day for 5 days per week, lasting for 3 weeks. Receives: Behavioral: Aromatherapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Respiratory sleep monitoring
The average length of sleep in a week Sleep breathing monitoring was determined by evaluation before and after treatment. The main purpose of this study was to observe whether the average sleep time of patients increased significantly after treatment.
Measured: From enrollment to the end of treatment for 3 weeks
Secondary outcomes (1)
Pittsburgh sleep quality index,PSQI
Pittsburgh sleep quality index（PSQI） The Pittsburgh Sleep quality Index (PSQI) was used to evaluate the sleep status of the patients before treatment and after three weeks of treatment. The total score of the scale was 0-21. The higher the score, the worse the sleep quality.
Measured: From enrollment to the end of treatment for 3 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Oct 2025
- Study start8 Oct 2025 (estimated)
- Primary completion30 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 6 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Dandan Wu
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Dandan Wu, Second Affiliated Hospital of Nanchang University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07202806
- Sponsor's protocol ID
- 2024B1366
- Status last verified
- Oct 2025
- First submitted
- 10 Sep 2025
- Last updated
- 2 Oct 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Study on the Application of Aromatherapy Combined With Transcranial Magnetic Stimulation in Insomnia of Stroke Patients
- ClinicalTrials.gov ID
- NCT07202806
- Acronym / sponsor ID
- 2024B1366
- Conditions
- Stroke
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 6 participants (estimated)
- Lead sponsor
- Dandan WuUniversity, hospital or other
- Study start
- 8 Oct 2025 (estimated)
- Primary completion
- 30 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 2 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Exploring the application efficacy of aromatherapy combined with transcranial magnetic stimulation on insomnia in patients with cerebral stroke
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| transcranial magnetic stimulation | No intervention | – |
| Aromatherapy + transcranial magnetic stimulation | Experimental | Behavioral: AromatherapyExperimental:Aromatherapy + transcranial magnetic stimulation 1.Aromatherapy is made from self-made sachet of traditional Chinese medicine.Its components (albizzia, Angelica dahurica, cardamom, Polygala, Evodia, Magnolia, Acorus calamus) are 10g each. Place the pillow 1 hour in advance. It is forbidden to play with your mobile phone or turn off the lights before going to bed.2.The r repetitive transcranial magnetic acupuncture apparatus produced by Jiangxi brain Control Technology Development Co., Ltd. is used and operated by professional therapists.Before treatment, the resting exercise threshold of each patient was tested: 10 pulse stimuli were given to find out the lowest stimulus intensity that could cause more than 50 microvolts.Parameter setting: 90% RMT 1Hz, each sequence lasts 12s, stimulation 10s, interval 2s. The treatment time was 20min/, once per day for 5 days per week, lasting for 3 weeks. |
Who may qualify
- Ages
- 24 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Clinical diagnosis of stroke
- Insomnia patients
- Sign the informed consent form, cooperate voluntarily
- Accord with the diagnosis of "insomnia" in traditional Chinese medicine
- Evaluation has no taboo on transcranial magnetism
Key exclusion criteria (5 listed)
- Disturbance of consciousness
- Cognitive impairment
- Mental abnormality
- Sleep apnea syndrome
- Restless leg syndrome
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Aromatherapy1.Aromatherapy is made from self-made sachet of traditional Chinese medicine.Its components (albizzia, Angelica dahurica, cardamom, Polygala, Evodia, Magnolia, Acorus calamus) are 10g each. Place the pillow 1 hour in advance. It is forbidden to play with your mobile phone or turn off the lights before going to bed. | Behavioural | Aromatherapy + transcranial magnetic stimulation |
Primary outcome
Respiratory sleep monitoring
Time frame: From enrollment to the end of treatment for 3 weeks
The average length of sleep in a week Sleep breathing monitoring was determined by evaluation before and after treatment. The main purpose of this study was to observe whether the average sleep time of patients increased significantly after treatment.
1 secondary outcome
Pittsburgh sleep quality index,PSQI
Time frame: From enrollment to the end of treatment for 3 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Oct 2025.
Related trials for Stroke
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
RecruitingObservational study
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
Acute Ichemic Stroke
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Aneurysm Hemorrhage
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Aromatherapy in people with Stroke, run by Dandan Wu.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 2 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Respiratory sleep monitoring (time frame: From enrollment to the end of treatment for 3 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2025.